HB 5593 Summary

• Removes "auto-injector" language restrictions to allow epinephrine administration in schools through multiple delivery mechanisms beyond auto-injectors, including inhalers and other appropriate forms.

• Expands liability protections for school employees, administrators, and school districts when administering epinephrine or opioid antagonists in good faith to individuals experiencing anaphylaxis or opioid overdose.

• Requires schools with 10+ staff to train at least 2 employees and smaller schools to train at least 1 employee in epinephrine administration under supervision of a licensed registered professional nurse.

• Mandates school boards stock at least 2 doses of epinephrine in each school and develop policies authorizing trained staff and nurses to administer epinephrine to pupils with prescriptions on file or to any individual experiencing anaphylaxis.

• Requires annual reporting to the Department of Education on all epinephrine administrations, including number of instances and pupils treated who were not previously known to be severely allergic; allows schools to seek reimbursement for unfunded compliance costs through legislative appropriation.